Clinical Trial Update: A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

View source ↗

Summary

This clinical trial update reports results from a study of Avelumab in Japanese patients with advanced urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Urothelial Carcinoma | Status: COMPLETED | Results posted: 2025-04-01